Loading…

Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane

(-)-Epigallocatechin gallate (EGCG), a major constituent of green tea, has been shown to exhibit anti-cancer activity. Sulindac is also well known as a cancer-preventive agent against colon cancer, but its usage is restricted because of its adverse effects, as exemplified by gastrointestinal bleedin...

Full description

Saved in:
Bibliographic Details
Published in:Cancer letters 2002-03, Vol.177 (1), p.49-56
Main Authors: Ohishi, Tomokazu, Kishimoto, Yosuke, Miura, Norimasa, Shiota, Goshi, Kohri, Toshiyuki, Hara, Yukihiko, Hasegawa, Junichi, Isemura, Mamoru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(-)-Epigallocatechin gallate (EGCG), a major constituent of green tea, has been shown to exhibit anti-cancer activity. Sulindac is also well known as a cancer-preventive agent against colon cancer, but its usage is restricted because of its adverse effects, as exemplified by gastrointestinal bleeding. In the present study, we examined whether a combination of EGCG and sulindac shows synergistic effects for cancer-preventive activity for rat colon carcinogenesis induced by azoxymethane (AOM); we examined the number of aberrant crypt foci (ACF) representing preneoplastic lesions, the argyrophilic nucleolar organizer region (AgNOR) as an indicator of cell proliferation, and the incidence of apoptosis. The AOM treatment induced an average of 46.2±4.9 ACF/colon, and sulindac and EGCG significantly reduced the incidence of ACF/colon to 21.4±3.4 and 19.5±5.8, respectively ( P
ISSN:0304-3835
1872-7980
DOI:10.1016/S0304-3835(01)00767-4